Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Burcon NutraScience Corp T.BU

Alternate Symbol(s):  BRCNF

Burcon NutraScience Corporation is a Canada-based global technology company focused on the development of plant-based proteins for foods and beverages. The Company has an extensive patent portfolio covering its novel plant-based proteins derived from pea, canola, soy, hemp and sunflower seeds, among other plant sources. The Company is engaged in the production of hemp protein isolate and provision of contract research services. Its products include hempseed protein, canola protein, pea proteins and protein blends. Its hempseed protein isolate extraction and purification/production process can produce a high-quality protein ingredient that contains 95% pure protein. It extracts and purifies a canola protein isolate from canola meal. It has branded this protein isolate under the trade name Puratein C. Peazazz is a soluble, clean and neutral-tasting pea protein. It provides consulting and contract services, product and process development, and process scale-up and validation.


TSX:BU - Post by User

Comment by fundmanager1944on Nov 15, 2021 4:45pm
193 Views
Post# 34129126

RE:RE:earnings

RE:RE:earnings
imartin wrote:

What was the royalty share again? 20 %?
Burcon made CAD32,000 from royalties, so at 20 % that means that during Q2, Merit sold protein for CAD160,000. 90,000 in the quarter before.

I was expecting much more, although the company communicated recently that only now, after commissioning is completed, larger orders are being fullfilled. So those CAD160,000 likely are the result of many smaller orders by companies that are trying out Merit's proteins on a small scale.

One good thing I guess is the smaller loss of CAD1.4M compared to CAD3.2M in the quarter before.



Agreed - AND that there is plenty of money left - until mid 2023
and this is calculated WITHOUT coming royalties 

<< Previous
Bullboard Posts
Next >>